Nvidia Stock Drop: Market Shift and AI Chip Delays
Discover the causes behind Nvidia's late-year stock sell-off, including market rotation from semiconductors to software and AI chip shipment delays.
Topic
Semiconductors
A collection of 88 issues
Market Shift: From Semiconductors to Software
Discover the market's latest trend as investors rotate focus from semiconductors to software. Stay updated with this shifting investment landscape.
AI Computing Boosts Chip Design and IP Value
Explore how AI computing growth enhances the value of chip design and intellectual property. Discover the intersection of AI and semiconductor innovation.
Nvidia Stock Dips as Investors Shift to Software
Investors are reallocating funds from the semiconductor sector to software, impacting Nvidia's stock performance. Discover how this trend affects tech investments.
Wingtech Sells Half of Nexperia to Focus on Chipmaking
Wingtech, parent of Nexperia, shifts strategy by divesting 50% of its business to enhance chipmaking capabilities. Key move in semiconductor industry.
GlobalFoundries Settles with IBM, Secures $1.5B Funding
GlobalFoundries resolves legal dispute with IBM and gains $1.5 billion from U.S. Commerce Department for production expansion. Explore the impact on the semiconductor industry.
U.S. Awards $1.5 Billion to GlobalFoundries for Chip Production
The U.S. Commerce Department grants $1.5 billion to GlobalFoundries to enhance domestic semiconductor production, boosting U.S. tech industry resilience.
Nvidia Set to Dominate Market with 80-85% Share
Explore Nvidia's expected market dominance with an 80% to 85% share in the next 12 to 18 months. Discover how Nvidia leads the tech industry.
Truist Lowers Intel's Stock Target to $22 Amid Semiconductor Concerns
Intel's stock target reduced to $22 by Truist, maintaining a hold rating due to cautious semiconductor and AI market outlook.
AI and Gaming Propel Tech and Semiconductors; Vaccine Boosts Healthcare
Explore the surge in tech and semiconductor sectors driven by AI and gaming innovations, alongside rising healthcare interest due to vaccine developments.